ReviewGastroenterology2022

Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis.

Rohit Loomba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.